Extraction and purification of a novel glycoprotein with antiviral activity from an Australian mollusc

从澳大利亚软体动物中提取和纯化具有抗病毒活性的新型糖蛋白

• 批准号: LP100100799
• 负责人: Prof Fariba Dehghani
• 金额: $ 33.47万
• 依托单位: The University of Sydney
• 依托单位国家: 澳大利亚
• 项目类别: Linkage Projects
• 财政年份: 2010
• 资助国家: 澳大利亚
• 起止时间: 2010-11-18 至 2014-07-31
• 项目状态: 已结题
• 来源: https://dataportal.arc.gov.au/RGS/Web/Grants/LP100100799
• 关键词: Extraction; purification; novel; glycoprotein; antiviral

Our aim is to develop the science that will enable the transformation of Australian seafood industry, a world leader in mollusc harvesting, into a value-added health and nutrition industry. We will develop a cost-effective technology for the extraction and production of high purity haemocyanin from the biomass produced in a Tasmanian seafood manufacturing process. We will demonstrate the potential of using haemocyanin for promoting the health and well-being of patients affected by the herpes simplex virus (HSV) and the human papilloma virus (HPV). New knowledge gained from the project will place Australia in the forefront of global treatment of infectious disease research and boost export earnings derived from molluscs' waste materials.

我们的目标是发展科学，使澳大利亚海产品行业，世界领先的软体动物收获，转化为一个增值的健康和营养行业。 我们将开发一种具有成本效益的技术，从塔斯马尼亚海鲜生产过程中产生的生物质中提取和生产高纯度血蓝蛋白。我们将展示使用血蓝蛋白促进受单纯疱疹病毒（HSV）和人乳头瘤病毒（HPV）影响的患者的健康和福祉的潜力。 从该项目中获得的新知识将使澳大利亚处于全球传染病治疗研究的前沿，并增加软体动物废料的出口收入。